Cargando…
YB1 Is a Major Contributor to Health Disparities in Triple Negative Breast Cancer
SIMPLE SUMMARY: Triple negative breast cancer (TNBC) is a devastating disease that affects many women, due to the lack of FDA-approved targeted therapy. In the absence of cell surface receptors ER, PR, and Her2 that can be targeted with hormonal and antibody treatments, cytotoxic chemotherapy remain...
Autores principales: | Rana, Priyanka Shailendra, Wang, Wei, Alkrekshi, Akram, Markovic, Vesna, Khiyami, Amer, Chan, Ricky, Perzynski, Adam, Joseph, Natalie, Sossey-Alaoui, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699660/ https://www.ncbi.nlm.nih.gov/pubmed/34944882 http://dx.doi.org/10.3390/cancers13246262 |
Ejemplares similares
-
The Role of WAVE2 Signaling in Cancer
por: Rana, Priyanka Shailendra, et al.
Publicado: (2021) -
The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer
por: Wang, Wei, et al.
Publicado: (2023) -
The WAVE2/miR-29/Integrin-β1 Oncogenic Signaling Axis Promotes Tumor Growth and Metastasis in Triple-negative Breast Cancer
por: Rana, Priyanka S., et al.
Publicado: (2023) -
Targeted Deletion of Kindlin-2 in Mouse Mammary Glands Inhibits Tumor Growth, Invasion, and Metastasis Downstream of a TGF-β/EGF Oncogenic Signaling Pathway
por: Wang, Wei, et al.
Publicado: (2022) -
Phosphorylation of the proline-rich domain of WAVE3 drives its oncogenic activity in breast cancer
por: Kansakar, Urna, et al.
Publicado: (2021)